Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TriMed Bonalive is a U.S. orthopedic medical device company and joint venture formed by TriMed and Bonalive Biomaterials to distribute Bonalive bone-regeneration products in the United States. Its core commercial product is Bonalive Orthopedics granules, an FDA-cleared implant made from S53P4 bioactive glass for filling bony voids and gaps in the extremities and pelvis. The product is positioned for orthopedic and trauma applications where bone regeneration is needed, including defects caused by benign bone cysts, tumors, surgery, or trauma. The company appears to function primarily as a U.S. commercialization and distribution vehicle rather than a broad R&D-stage biotech developer. Its business is healthcare-related, but centered on biomaterials and implantable devices rather than drug therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TriMed Bonalive.